New Marketlink Pharmaceutical

New Marketlink Pharmaceutical Corporation (NMPC) is a leading Filipino-owned pharmaceutical company specializing in the marketing and distribution of a diverse range of healthcare products. Established in 2006 and headquartered in Pasig City, NMPC operates as a key subsidiary of the TAO Corporation and the Marketlink Group. The company manages a robust portfolio of both ethical (prescription) and over-the-counter (OTC) medicines, covering therapeutic areas such as cardiology, nephrology, respiratory health, and anti-infectives. NMPC is well-known for distributing prominent international brands like Isoprinosine and the Rowatinex line, as well as local herbal solutions like Lagundex. With a nationwide distribution network and a commitment to quality, the company plays a vital role in improving healthcare accessibility and patient outcomes in the Philippines.